[A prospective study on erysipelas and infectious cellulitis: how are they dealt within hospital?] | Canada Hyperbarics Skip to main content
Review Ann Dermatol Venereol 2001

[A prospective study on erysipelas and infectious cellulitis: how are they dealt within hospital?]

Schmit J — Ann Dermatol Venereol, 2001

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a three-month study in French hospitals to observe how erysipelas and infectious cellulitis cases were treated.

What They Found

The study found that erysipelas patients had an 86.6% cure rate without complications and a 0.77% death rate, with a median hospital stay of 8 days. For infectious cellulitis, the cure rate without complications was 48.1%, the death rate was 5.7%, and the median hospital stay was 21 days; 4.2% of cellulitis patients received hyperbaric oxygen therapy.

What This Means for Canadian Patients

This study highlights the different treatment approaches and outcomes for erysipelas and infectious cellulitis, two common skin infections. While hyperbaric oxygen therapy (HBOT) was used in a small number of severe cellulitis cases, its role in improving outcomes for Canadian patients with these conditions would require further specific investigation.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study was conducted over 20 years ago in French hospitals, and its observational design does not allow for conclusions about the effectiveness of specific treatments like hyperbaric oxygen therapy.

Was this summary helpful?

Study Details

Study Type Review
Category Infection
Source Pubmed
PubMed ID 11319360
Year Published 2001
Journal Ann Dermatol Venereol
MeSH Terms Erysipelas; Fasciitis, Necrotizing; Female; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Surveys and Questionnaires

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.